BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 14575851)

  • 1. In vivo thermoluminescence dosimetry dose verification of transperineal 192Ir high-dose-rate brachytherapy using CT-based planning for the treatment of prostate cancer.
    Anagnostopoulos G; Baltas D; Geretschlaeger A; Martin T; Papagiannis P; Tselis N; Zamboglou N
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(4):1183-91. PubMed ID: 14575851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solid state TL detectors for in vivo dosimetry in brachytherapy.
    Gambarini G; Borroni M; Grisotto S; Maucione A; Cerrotta A; Fallai C; Carrara M
    Appl Radiat Isot; 2012 Dec; 71 Suppl():48-51. PubMed ID: 22920417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In regard to Anagnostopoulos et al.: In vivo thermoluminescence dosimetry dose verification of transperinal (192)Ir high dose rate brachytherapy using CT-based planning for the treatment of prostate cancer (Int J Radiat Oncol Biol Phys 2003;57:1183-1191).
    Duggan L; Bucci J; Kron T
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):911; author reply 911-2. PubMed ID: 15183495
    [No Abstract]   [Full Text] [Related]  

  • 4. Thermoluminescence dosimetry for in-vivo verification of high dose rate brachytherapy for prostate cancer.
    Das R; Toye W; Kron T; Williams S; Duchesne G
    Australas Phys Eng Sci Med; 2007 Sep; 30(3):178-84. PubMed ID: 18044301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo urethral dose measurements: a method to verify high dose rate prostate treatments.
    Brezovich IA; Duan J; Pareek PN; Fiveash J; Ezekiel M
    Med Phys; 2000 Oct; 27(10):2297-301. PubMed ID: 11099197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality control in interstitial brachytherapy of the breast using pulsed dose rate: treatment planning and dose delivery with an Ir-192 afterloading system.
    Mangold CA; Rijnders A; Georg D; Van Limbergen E; Pötter R; Huyskens D
    Radiother Oncol; 2001 Jan; 58(1):43-51. PubMed ID: 11165681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate seed implantation using 3D-computer assisted intraoperative planning vs. a standard look-up nomogram: Improved target conformality with reduction in urethral and rectal wall dose.
    Raben A; Chen H; Grebler A; Geltzeiler J; Geltzeiler M; Keselman I; Litvin S; Sim S; Hanlon A; Yang J
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1631-8. PubMed ID: 15590195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo TLD dose measurements in catheter-based high-dose-rate brachytherapy.
    Adlienė D; Jakštas K; Urbonavičius BG
    Radiat Prot Dosimetry; 2015 Jul; 165(1-4):477-81. PubMed ID: 25809111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: a feasibility report.
    Martinez AA; Pataki I; Edmundson G; Sebastian E; Brabbins D; Gustafson G
    Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):61-9. PubMed ID: 11163498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-time in vivo dosimetry in high dose rate prostate brachytherapy.
    Mason J; Mamo A; Al-Qaisieh B; Henry AM; Bownes P
    Radiother Oncol; 2016 Aug; 120(2):333-8. PubMed ID: 27236248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using LiF:Mg,Cu,P TLDs to estimate the absorbed dose to water in liquid water around an 192Ir brachytherapy source.
    Lucas PA; Aubineau-Lanièce I; Lourenço V; Vermesse D; Cutarella D
    Med Phys; 2014 Jan; 41(1):011711. PubMed ID: 24387503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetric impact of contouring and needle reconstruction uncertainties in US-, CT- and MRI-based high-dose-rate prostate brachytherapy treatment planning.
    Rylander S; Buus S; Pedersen EM; Bentzen L; Tanderup K
    Radiother Oncol; 2017 Apr; 123(1):125-132. PubMed ID: 28284493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-time dose-rate monitoring with gynecologic brachytherapy: Results of an initial clinical trial.
    Belley MD; Craciunescu O; Chang Z; Langloss BW; Stanton IN; Yoshizumi TT; Therien MJ; Chino JP
    Brachytherapy; 2018; 17(6):1023-1029. PubMed ID: 30150015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraoperative ultrasound-based planning can effectively replace postoperative CT-based planning for high-dose-rate brachytherapy for prostate cancer.
    Batchelar DL; Chung HT; Loblaw A; Law N; Cisecki T; Morton GC
    Brachytherapy; 2016; 15(4):399-405. PubMed ID: 27180126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An integrated system for clinical treatment verification of HDR prostate brachytherapy combining source tracking with pretreatment imaging.
    Smith RL; Hanlon M; Panettieri V; Millar JL; Matheson B; Haworth A; Franich RD
    Brachytherapy; 2018; 17(1):111-121. PubMed ID: 28958735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a phantom to validate high-dose-rate brachytherapy treatment planning systems with heterogeneous algorithms.
    Moura ES; Micka JA; Hammer CG; Culberson WS; DeWerd LA; Rostelato ME; Zeituni CA
    Med Phys; 2015 Apr; 42(4):1566-74. PubMed ID: 25832047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraoperative Registered Ultrasound and Fluoroscopy (iRUF) for dose calculation during prostate brachytherapy: Improved accuracy compared to standard ultrasound-based dosimetry.
    Lee J; Mian OY; Le Y; Bae HJ; Burdette EC; DeWeese TL; Prince JL; Song DY
    Radiother Oncol; 2017 Jul; 124(1):61-67. PubMed ID: 28647400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Online correction of catheter movement using CT in high-dose-rate prostate brachytherapy.
    Huang Y; Miller B; Doemer A; Babij D; Kumar S; Frontera R; Nurushev T; Chetty IJ; Aref I
    Brachytherapy; 2013; 12(3):260-6. PubMed ID: 23453680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High dose-rate afterloading 192Iridium prostate brachytherapy: feasibility report.
    Mate TP; Gottesman JE; Hatton J; Gribble M; Van Hollebeke L
    Int J Radiat Oncol Biol Phys; 1998 Jun; 41(3):525-33. PubMed ID: 9635698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intraoperative and post-implant dosimetry in patients treated with permanent prostate implant brachytherapy].
    Herein A; Ágoston P; Szabó Z; Jorgo K; Markgruber B; Pesznyák C; Polgár C; Major T
    Magy Onkol; 2015 Jun; 59(2):148-53. PubMed ID: 26035163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.